Explore the detailed record of transactions filed by Oliviero James F III, Chairman & CEO. Insider active across 1 companies, notably Checkpoint Therapeutics, Inc.. Cumulatively, 4 reports have been published. Total volume traded: €236k. The latest transaction was filed on 17 June 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations
Oliviero James F III serves as President, Chief Executive Officer, and Board Member of Checkpoint Therapeutics, Inc. In this role, he leads the company's operations and develops strategies to achieve growth objectives. His expertise in the biopharmaceutical field is essential for Checkpoint, which focuses on developing innovative cancer treatments. Oliviero is committed to improving patient health through advanced therapeutic solutions.